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Abstract  24 
Introduction 25 
Influenza is a major cause of disease in children. School-based seasonal influenza vaccination can 26 
be a cost-effective tool to improve vaccine uptake among children, and can bring substantial 27 
health and economic benefits to the broader community. The acceptance and feasibility of school-28 
based influenza vaccination are likely to be highly context-specific, but limited data exist from 29 
tropical settings with year-round influenza transmission. We conducted a qualitative study to 30 
assess acceptability and feasibility of a school-based seasonal influenza vaccination programme 31 
in Singapore. 32 
Methods 33 
We conducted qualitative in-depth interviews with key stakeholders, including healthcare 34 
professionals, representatives of relevant ministries, preschool principals and parents to 35 
understand their perspectives on a proposed school-based seasonal influenza vaccination 36 
programme. Interviews were transcribed verbatim and analysed using thematic analysis.  37 
Results 38 
We conducted 40 interviews. Although preschool-aged children are currently the recommended 39 
age group for vaccination, stakeholders suggested introducing the programme in primary and/or 40 
secondary schools, where existing vaccination infrastructure would facilitate delivery. However, 41 
more comprehensive evidence on the local influenza burden and transmission patterns among 42 
children is required to develop an evidence-based, locally relevant rationale for a school-based 43 
vaccination programme and effectively engage policy-makers, school staff, and parents. Extensive, 44 
age-appropriate public education and awareness campaigns would increase the acceptability of 45 
the programme among stakeholders. Stakeholders indicated that an opt-out programme with free 46 
or subsidised vaccination would be the most likely to achieve high vaccine coverage and make 47 
access to vaccination more equitable.  48 
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Conclusions 49 
Overall, participants were supportive of a free or subsidised school-based influenza vaccination 50 
programme in primary and/or secondary schools, although children in this age group are not 51 
currently a recommended group for vaccination. However, a better informed, evidence-based 52 
rationale to estimate the programme’s impact in Singapore is currently lacking. Extensive, age-53 
appropriate public education and awareness campaigns will help ensure full support across key 54 
stakeholder groups. 55 
 56 
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Introduction 71 
Influenza causes an estimated 9.5 million hospitalisations and 81 million hospitalisation days 72 
worldwide each year [1]. Young children are a particularly vulnerable group, because they have 73 
lower levels of immunological protection and high levels of contact with other potentially 74 
infectious children [2]. The World Health Organization currently recommends annual vaccination 75 
of children aged 6-59 months [3]. Data from high and middle-income countries show that 76 
seasonal influenza vaccination of preschool- and school-aged children can effectively reduce the 77 
incidence of influenza among vaccines [4–10], and confer indirect protection to unvaccinated 78 
individuals in the community [11,12].  79 
Studies investigating the acceptance of seasonal school-based influenza vaccination programmes 80 
(SIVPs), primarily conducted among parents, have identified numerous perceived benefits of 81 
such programmes, including greater convenience [13–15], increased vaccine access [15,16], 82 
reduced student and teacher absenteeism and associated costs [13–15], opportunities to 83 
incorporate health education into teaching [15], and broader benefits such as better pandemic 84 
preparedness [15]. Studies have also identified perceived harms and challenges of SIVPs, 85 
including the potential for side effects [13,14], lack of confidence in the school as an environment 86 
to receive vaccination [14], disruption to teaching time [14,15], and inadequate information 87 
about vaccination programmes [15].  88 
In Singapore, influenza transmission occurs year-round, with two peaks of increased activity 89 
coinciding with the Northern and Southern hemisphere influenza seasons [17]. Virological 90 
surveillance indicates that a large proportion of acute respiratory illnesses seen at primary care 91 
facilities is caused by influenza [17]. Since 2014, Singaporean Citizens and Permanent Residents 92 
in influenza high-risk groups can claim for the influenza vaccine using Medisave, a mandatory 93 
medical savings scheme. However, coverage of influenza vaccine among high-risk groups, such as 94 
children [18] and elderly [19] is low (≤15%).  95 
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Introduction of a seasonal SIVP could bring substantial direct and indirect health and economic 96 
benefits in Singapore. Potential challenges related to the associated logistics, cost and public 97 
acceptance of such a programme, which are likely to be highly specific to the local context, have 98 
not been studied. This study assessed stakeholder perceptions of the feasibility and acceptability 99 
of a seasonal SIVP in Singapore.  100 
Methods 101 
Recruitment 102 
Between May 2017 and November 2018, we recruited representatives from different stakeholder 103 
groups with an interest in childhood vaccination in Singapore. Among healthcare professionals, 104 
we interviewed private general practitioners (GPs), polyclinic doctors, paediatricians and 105 
infectious disease specialists. We also included representatives of the Health Promotion Board 106 
(HPB), a government agency responsible for delivery of routine immunisations in primary 107 
schools, and the Ministry of Health (MoH), as well as preschool principals and parents of children 108 
aged 18 months to seven years. Parents were eligible to participate if they were aged 21 years 109 
and above and if they were the main health decision-maker for their child. We excluded parents 110 
who were not able to complete the interview in English, and those whose children had a history 111 
of known serious allergic reaction to the influenza vaccine. 112 
Potential interviewees from healthcare and government institutions were recruited through an 113 
invitation sent to their official e-mail addresses describing the study’s aims and methods. Parents 114 
and preschool principals were sampled through convenient sampling from participants in a 115 
prospective surveillance study of respiratory infections in child care centres in Singapore [20], 116 
who had previously consented to being re-contacted for related studies.  117 
In-depth interviews 118 
In order to gain a detailed understanding of each individual participant’s perspectives and 119 
preferences, we opted for in-person in-depth interviews (IDIs). The IDIs explored participants’ 120 
attitudes and practices related to influenza and the seasonal influenza vaccine, and elicited their 121 
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views about the feasibility and acceptability of a proposed SIVP. The IDI guide was tailored to 122 
individual stakeholder groups. For example, MoH representatives were asked to elaborate more 123 
on issues of cost-effectiveness, while preschool principals were asked to expand on issues around 124 
logistics or child well-being.  125 
Before commencing the IDI, a trained interviewer answered all questions from participants and 126 
audio-recorded their verbal consent to take part in the study. Interviewers posed probing questions 127 
until a full understanding of each participant’s perspective was reached. Each IDI took approximately 128 
20-45 minutes to complete and was audio-recorded. A note-taker took detailed notes throughout 129 
the interview. Parents were also reimbursed for their time with a S$50 voucher and given an 130 
information pamphlet on influenza and the seasonal influenza vaccine. 131 
Sample size  132 
We aimed to interview up to 50 participants from different stakeholder groups. The target sample 133 
size was based on the inclusion of local infectious disease specialists and relevant representatives 134 
from government institutions, and a predicted thematic saturation of approximately 10-12 135 
interviews in each group among healthcare professionals, preschool principals, and parents [21], 136 
with some allowance for extra interviews if saturation was not reached [22]. Within each of these 137 
interviewee group, data saturation was considered achieved when no new themes emerged 138 
during the IDIs and the core meaning of existing codes remained unaltered [23,24]. 139 
Data analysis 140 
IDIs were transcribed verbatim and analysed by thematic analysis using nVivo 11 software [25]. 141 
Potentially identifying data was removed. Two investigators (VO and SS) independently coded 142 
three transcripts and reached consensus on the codebook. Discrepancies were resolved through 143 
discussion with a third investigator (GK). One investigator (VO) subsequently coded the 144 
remaining transcripts. Emerging themes were compared within and across stakeholder groups 145 
and arranged into higher-order themes. 146 
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Ethics approval 147 
This study was approved by the National University of Singapore Institutional Review Board 148 
(reference number: B-16-232).  149 
Results 150 
Main themes 151 
We conducted a total of 40 IDIs. Among government officials, we interviewed three 152 
representatives of the MoH, as well as seven members of the HPB’s School Health Services 153 
division. We also interviewed 19 primary healthcare professionals and two hospital infectious 154 
disease specialists, as well as five preschool principals and four parents (Table 1). Overall, three 155 
main themes emerged from IDIs across stakeholder groups: logistics, stakeholder engagement, 156 
and funding (Figure 1). Within each of these themes, stakeholders indicated a number of 157 
challenges to the successful implementation of a seasonal SIVP in Singapore, and put forward 158 
suggestions to address these in the SIVP’s design and implementation, in order to achieve specific 159 
outcomes. 160 
Logistics  161 
Stakeholders indicated several logistical challenges to the successful implementation of school-162 
based influenza vaccination in Singapore, including the need to purchase large vaccine stocks, the 163 
increased workload for school staff, and the lack of appropriate cold-chain storage facilities and 164 
vaccination venues at schools. In particular, stakeholders discussed in detail the preferred setting 165 
for a potential SIVP, and the mechanism for vaccine delivery. 166 
SIVP setting 167 
Although preschool-aged children are the recommended age group for influenza vaccination, 168 
most stakeholders suggested to introduce the programme in primary and/or secondary schools, 169 
where existing vaccination infrastructure would facilitate delivery (Figure 1A):  170 
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“For the older children, it may be easier in terms of operation, because […] you have School 171 
Health Services going to these schools to run other vaccination programmes, and [so it] may 172 
be feasible.” (MoH2) 173 
Singapore offers a wide range of preschool options, including public and private child care 174 
centres, kindergartens, and informal play groups. This would substantially complicate the 175 
recruitment of preschools for a potential SIVP:  176 
“Preschool[s] might be hard to target. Primary [and] secondary […] might be easier to do if 177 
they have a proper mandate to roll out [the programme in] a government school, rather 178 
than preschools that are privately owned.” (IDS2)  179 
In addition, a SIVP implemented in primary and/or secondary schools would likely reach more 180 
children, because school attendance is mandated from the age of six years: 181 
“There are children who are home-schooled up to primary school, [who] may not be 182 
captured. […] The pick-up rate will be higher if we start in primary school, because [the] 183 
majority of children in our country go to a public primary school.” (PY6)  184 
A preschool principal explained that vaccine administration would also be easier among older 185 
children:  186 
“I think primary school will be more appropriate. For preschool, children are still very young, 187 
and […] if parents are not around, it would not be very easy for teachers to manage the 188 
child’s reaction to the jab, while managing all the other children.” (PP1) 189 
Finally, parents of older children may worry less about potential side effects of the vaccine, and 190 
thus be more inclined to accept vaccination in school settings:  191 
“I think [we] should try in primary school first. […] I think primary school parents are much 192 
more receptive towards this, because their children are older. The tendency that their 193 
children might fall sick because of the vaccine, or things like that, there are lesser worries 194 
about it.” (PP4 )  195 
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Vaccine delivery 196 
Regardless of the specific school setting, there was disagreement among participants on the 197 
appropriate mechanism for vaccine delivery. Stakeholders discussed commissioning vaccination 198 
to “a nurse or an equivalent stationed on site as part of the school infrastructure” (PubPD1), or 199 
rotating vaccination teams:  200 
“In [the] UK […] you actually have nurses who […] go around visiting all the schools […], even 201 
carrying out vaccination […]. So I think that’s probably a good model to look at.” (GP1) 202 
However, both these options would result in prolonged vaccination timelines. A school-based 203 
nurse might be able to vaccinate “20 kids a day” (PubPD1), requiring up to one year to administer 204 
the vaccine to all students in one school. Similarly, a rotating staff model would impede targeted 205 
cohort vaccination at the start of the peak influenza season:  206 
“Because of how teams visit schools one after the other, it is difficult to vaccinate all children 207 
at once. Children from different schools will be vaccinated at different times over the year. 208 
Doing so might still give them the immunity, but [I’m] not sure it is as effective as giving 209 
them [the vaccine] before the peak season.” (HPB5) 210 
In addition, one HPB representative argued that 211 
“even though adverse events are very rare, doctors need to be there to assess if [the] child is 212 
fit for vaccination before giving the vaccination.” (HPB5)  213 
However, doctors’ participation would be conditional on their time availability and perceived 214 
benefits: 215 
“Some general practitioners will be keen on it, others won’t. So if general practitioners have 216 
the time, the inclination, [and] the ability to take […] a morning off to go and [vaccinate], 217 
[and if] they think it’s something worthwhile for them to do, then [the programme] could be 218 
well-received. [General practitioners] would be expecting to be paid for their time.” (GP1)  219 
Stakeholder engagement 220 
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Most interviewees agreed that the success of a proposed SIVP would strongly depend on the 221 
effective engagement of key stakeholder groups, including policy-makers, school staff, and 222 
parents (Figure 1B). According to participants, developing an evidence-based, locally relevant 223 
rationale that justifies the introduction of a seasonal SIVP in Singapore would increase its 224 
acceptability among stakeholders (Figure 1B). However, more comprehensive evidence on the 225 
local influenza burden and transmission patterns is currently needed:  226 
“The problem that one would face when [going] to a policy maker with such a proposal 227 
would be: could you quantify the burden of influenza due to transmission in the school, 228 
versus transmission in the community? […] I don’t know whether we actually have such 229 
granularity on where influenza exists. […] So my concern with such a proposal would be, if 230 
you go to a school, they will say: ‘can you tell me what the burden of influenza [is] in the 231 
school?’ And nobody would be able to give a single statistic.” (PubPD1) 232 
Different stakeholders also highlighted the importance of complementing epidemiological data 233 
with context-specific cost-effectiveness analyses:  234 
"[A SIVP is] something that would require some form of cost-effectiveness analysis. […] Is 235 
that the best use of resources? […] If it is not cost-effective, then you are in fact putting more 236 
burden on the healthcare system as a whole.” (MoH2) 237 
In addition, participants suggested the proposed SIVP should be complemented with extensive, 238 
age-appropriate public education and awareness campaigns about influenza and the influenza 239 
vaccine. Some stakeholders specifically indicated school staff as an important target of public 240 
education: 241 
“I think teachers in general are knowledgeable, but they may have incorrect ideas from 242 
social media, from the negative internet sites etc., on what […] the true, so-called utility of 243 
vaccination [is]. And um, many of them may still subscribe, or are subscribed to alternative 244 
medicine. […] I think that can be further educated, so I think that’s the important bit.” 245 
(PubPD1) 246 
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In addition, persuading parents and children about the importance of vaccination would be key 247 
to ensuring high vaccination uptake (Figure 1B and 1C):  248 
“I think parents need to be updated, educated, and persuaded. […] Uh, then I guess there 249 
must be education to children, […] so that they understand and don’t fear, and they accept. 250 
[…] Because if we roll it out and then half the population is absent, then you’re stuck again.” 251 
(PrivPD1)  252 
Improved levels of public education would also help address potential issues with vaccination-253 
related adverse events:  254 
“We need to educate people [about] what expected [adverse] events [are]. […] I think we 255 
need to have a good understanding of the background rates of events of interest, and then 256 
when we embark upon this, we will say ‘Look, it is still a background rate’. Or, if [the rate] is 257 
increased, we know it’s supposed to be increased to this amount, and no more. […] That’s 258 
what I mean by anticipation. […] If we do vaccinate this number of people, we publicly tell 259 
people, we will probably see an increase in certain events for a while.“ (PubPD1)  260 
Funding 261 
Stakeholders generally concurred that an opt out programme with free or subsidised vaccination 262 
would be the most likely to achieve high vaccine coverage (Figure 1C). If parents were asked to 263 
bear the cost of vaccination, a subsidy would help to increase the programme’s acceptability:  264 
“At the end of the day, I think it should be the parents who bear the cost, but of course some 265 
perks will always entice parents, you know. […] If you give them some form of subsidy, […] 266 
maybe [they will not] feel sober about the payment then.” (PP3) 267 
A free or subsidised SIVP would also make access to vaccination more equitable (Figure 1C):  268 
“If you […] say ‘okay, we want you to pay for [the vaccine]’, [it] may be difficult for those in 269 
the lower socioeconomic groups. And then that can create a sort of a two-tier system, and 270 
parents are going to feel bad because they can’t afford to pay for that for their child. […] So 271 
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if you want to offer [the vaccine] in schools, I suspect that you either need to make it very 272 
cheap or free.” (GP1) 273 
Different interviewees suggested that the funding mechanism for the vaccine would also depend 274 
on the choice of consent model (Figure 1C):  275 
“Once [the programme] is opt out, then actually the government should pay. If it is going to 276 
be opt in, then probably the consumer.” (PriPD4) 277 
Some stakeholders recognised that vaccination of large paediatric cohorts may substantially 278 
reduce the cost per dose of the vaccine. Nonetheless, a common worry among study participants 279 
was that a seasonal SIVP may consume a large amount of financial resources, stripping other, 280 
perhaps more important healthcare priorities of funding:  281 
“So, if such a big amount of funding [is] poured into vaccination, […] funding [for] other 282 
diseases, prevention, all that, might be much less. And I fear that the impact to other sides 283 
may be ignored.” (PY3)  284 
For this reason, one representative from MoH recommended that the local need for a SIVP be 285 
carefully evaluated in relation to other areas of healthcare, and its value reassessed periodically: 286 
“[An] influenza school-based programme […] may not run effectively after like two to three 287 
years down the road. Yeah, so that is a time where you need to evaluate again whether a 288 
school-based programme is still useful to keep.” (MoH3)  289 
Benefits and negative impacts of SIVP 290 
The majority of participants viewed a SIVP as the most effective way to increase influenza vaccine 291 
coverage in the paediatric population in Singapore: 292 
“I think it is going to be effective, because […] access gets much easier. Because one of the 293 
things parents have to do is take their children out of the school and, you know, they have to 294 
make appointments to come to the hospitals […]. Giving [the vaccine] at school might help. 295 
[…] It [will] improve […] uptake.” (PD03) 296 
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From the perspective of parents, major barriers to vaccinating children include the inconvenience 297 
of attending yearly vaccination appointments, as well as overly complicated reimbursement 298 
procedures for the cost of the vaccine. In addition, time constraints during patient consultations 299 
currently prevent general practitioners from promoting and administering the influenza vaccine 300 
in their practice: 301 
“Because we are so busy, sometimes we don’t even have time to manage the medical 302 
problems per se. So preventive medicine is not [a priority]. Not just the influenza, even the 303 
pneumococcal and cervical cancer vaccinations. […] If we have 30 minutes with one patient 304 
to go through all their medical problems, definitely by right we need to do the preventive 305 
care part right. But […] it is a time issue.”  (PY06) 306 
Participants perceived the proposed SIVP as a useful tool to help overcome these specific barriers. 307 
Most interviewees acknowledged that increased vaccination coverage would significantly reduce 308 
the health and healthcare burden due to influenza through both direct protection of school 309 
children and indirect protection among their unvaccinated contacts: 310 
“[High vaccine coverage] does provide a certain proportion of herd immunity. Because all 311 
these kids are in the community. So [vaccination] protect[s] against [influenza] at home, in 312 
school, in public places.” (PY2) 313 
This would ultimately reduce school and work absenteeism among children and adults, 314 
respectively. However, not all participants agreed that increasing influenza vaccine uptake 315 
among children would be necessary in Singapore. Some participants expressed low confidence in 316 
the vaccine’s effectiveness: 317 
“We need to have a better vaccine. Despite the very high rates of vaccination in developed 318 
countries, you still got thousands of influenza cases and hundreds of deaths […]. If we had a 319 
vaccine of [higher] quality, then I think people would line up to get it, and it could justify […]  320 
funding it publicly.” (IDS1) 321 
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The misconception that influenza vaccination is only required before travelling overseas was 322 
common among parents, and reflected in GPs’ vaccine recommendation practices. Some 323 
participants suggested a seasonal SIVP may help curb such misconceptions by increasing public 324 
education and awareness of influenza and the influenza vaccine, because “if you [vaccinate] in 325 
schools, it forces people to think about it.” (GP1) 326 
However, one concern raised by participants was the possibility that parents may then direct 327 
questions about the influenza vaccine to school staff, rather than medically qualified healthcare 328 
professionals. As one polyclinic doctor suggested, this would require a proposed SIVP to include 329 
“dedicated, trained personnel” (PY6) to address parents’ queries. 330 
In addition, the negative publicity arising from vaccination adverse events was indicated as one 331 
possible negative impact of a proposed SIVP:  332 
“By the same token of [a SIVP] being a very visible event, any negative impact would also be 333 
a very visible event.” (PubPD1) 334 
This might cause unwarranted worry among the public, likely putting “the whole concept of 335 
vaccination [in] negative light.” (PubPD4) 336 
Discussion 337 
This study evaluated the feasibility and acceptability of a seasonal SIVP in Singapore. Key 338 
stakeholders indicated a number of logistical and financial challenges to the implementation of a 339 
proposed SIVP, and suggested its feasibility would be highest in primary and/or secondary 340 
schools. Successful involvement of key stakeholders would require extensive public education 341 
campaigns, as well as the development of an evidence-based, locally relevant rationale that 342 
justifies the introduction of a SIVP in Singapore. An opt out programme with free or subsidised 343 
vaccination would achieve the highest coverage and ensure equitable access to vaccination.  344 
While the existing evidence demonstrates that the introduction of seasonal SIVPs can have 345 
substantial health [4–10,26–28] and economic [29,30] benefits for the wider community, this and 346 
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previous studies [15,31–37] suggest that the successful implementation of such programmes may 347 
depend on more qualitative, context-specific aspects. A review of SIVPs in high-income countries 348 
identified considerable administrative and logistical challenges to the successful delivery of 349 
vaccines in schools, including the choice of organisational and funding models, the logistics of 350 
vaccine supply and distribution, issues around staff capacity and workload, and communication 351 
with parents and students [35]. The rationale for introducing school-based vaccination and the 352 
choice of vaccine target groups were indicated as main determinants of programme effectiveness 353 
[35].  354 
The preference for vaccination in older children expressed by stakeholders in this study is 355 
challenged by current influenza vaccine recommendations in Singapore, which only include 356 
children aged five years and below [38]. The rationale underlying this recommendation is based 357 
on young children’s high vulnerability to influenza infection and influenza-related complications 358 
[2,39], as well as their key role as influenza transmitters in the community [39]. However, 359 
simulation models show that school-aged children can also play a leading role in propagating 360 
influenza outbreaks [40], and that targeted vaccination of children in this age group can have the 361 
greatest impact on reducing transmission during epidemics [40]. Accordingly, influenza 362 
transmission rates have been shown to fluctuate with school opening and closure periods [41,42].  363 
There is substantial evidence of indirect protective benefits to unvaccinated groups from 364 
vaccinating school-aged children [4–10,26–28,43–50].  However, the majority of evidence on the 365 
impact and cost-effectiveness of seasonal SIVPs comes from studies in North America and Europe, 366 
which have different vaccine financing mechanisms and influenza epidemiology compared to 367 
Singapore. Few studies have been conducted in tropical settings, which have the added 368 
complication of experiencing biannual transmission seasons. A comprehensive assessment of the 369 
influenza burden and transmission patterns among young age groups would be essential to 370 
understand children’s role in propagating influenza in the local context and develop a locally 371 
relevant rationale for the implementation of a seasonal SIVP. In Singapore, an integrated national 372 
influenza surveillance programme administered by the MoH includes community surveillance of 373 
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acute respiratory infections through public hospitals and polyclinics, virological surveillance of 374 
influenza viruses, veterinary surveillance of poultry and bird populations, and external 375 
surveillance of regional and global infectious disease incidents [51]. However, there are no 376 
dedicated influenza surveillance mechanisms that capture disease and transmission patterns 377 
specifically in children.  378 
Most participants were forthcoming during the IDIs, and individual stakeholders demonstrated a 379 
deep understanding of issues related to influenza and the influenza vaccine. However, our study 380 
population displayed a general disinterest in the topic of influenza vaccination. Parents were only 381 
marginally interested in discussing a potential SIVP, and did not engage in more detailed 382 
conversations on issues directly relevant to them, such as consent procedures or child well-being 383 
on the day of vaccination. No new themes emerged among parents after four interviews. Factors 384 
potentially increasing parents’ willingness to consent to a SIVP mostly emerged from IDIs with 385 
preschool principals and GPs. Parents’ inertia towards influenza vaccination and a proposed SIVP 386 
is in contrast to previous findings from the USA, showing that parents who are relatively 387 
knowledgeable with regards to influenza and the influenza vaccine can be very cognizant of the 388 
public health benefits associated with SIVPs [14,52]. Misconceptions on influenza and the 389 
influenza vaccine, such as the belief that the vaccine is only required before travel, were common 390 
among all stakeholder groups. One participant pointed to the need to quantify and compare the 391 
intensity of influenza transmission in schools versus other locations in the community, in order 392 
to justify nation-wide vaccination of school children. However, the view that vaccination should 393 
occur where transmission is most intense is misguided, because an immunised individual 394 
exposed to influenza might be protected regardless of where vaccination occurred. The observed 395 
indifference and misinformation in our study population reflect the need for more 396 
comprehensive, targeted education and awareness efforts among providers and the public in 397 
Singapore.  398 
Limitations 399 
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Representatives of the Ministry of Education (MoE) and Early Childhood Development Agency 400 
were not available to participate in this study. This prevented a more thorough investigation of 401 
aspects that might be relevant to the educational sector, such as the potential disruption of 402 
lessons or reduced absenteeism at schools. We were also unable to include stakeholders from the 403 
primary school sector, which is overseen and centrally managed by the MoE. This study does not 404 
include the perspectives of non-English speaking stakeholders. However, the vast majority of 405 
young parents and all other stakeholder groups included in this study are fluent in English in 406 
Singapore. Because we did not interview parents of children older than seven years, we were 407 
unable to corroborate other stakeholders’ statements on parental acceptance of vaccination in 408 
the primary and/or secondary school setting, or parents’ concerns about potential side effects 409 
among older children. Finally, our sample of healthcare professionals, parents, and teachers 410 
might be skewed towards pro-vaccine individuals, or those who are generally more interested in 411 
vaccine-related topics. Thus, the opinions and attitudes expressed in this analysis may reflect 412 
those of stakeholders who are more supportive of vaccination.  413 
Conclusions 414 
Understanding context-specific barriers and facilitators of childhood influenza vaccination can 415 
help shape interventions to increase influenza vaccine coverage among young children. This 416 
study evaluated the feasibility and acceptability of a seasonal SIVP in Singapore, providing 417 
essential evidence to inform policy for future programmes. Overall, participants were supportive 418 
of a proposed seasonal SIVP in Singapore. However, a better informed, evidence-based rationale 419 
is required to gain full support across stakeholder groups and estimate the programme’s impact 420 
in Singapore.  421 
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Figure Legends 613 
Figure 1. Main Themes Three main themes emerging from in-depth interviews with 614 
stakeholders, including A) Logistics, B) Stakeholder engagement, and C) funding; trapezoids: 615 
challenges to implementation of a seasonal school-based influenza vaccination programme in 616 
Singapore; ovals: stakeholders’ suggestions to overcome these challenges; rectangles: possible 617 
outcomes if specific suggestions were followed.  618 
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Tables 619 
Table 1. Number of participants interviewed in this study by stakeholder group 620 
Stakeholder group Acronym Number of interviewees 
Ministry of Health MoH 3 
Health Promotion Boarda HPB 7 
Public hospital infectious disease specialists IDS 2 
Public hospital paediatricians PubPD 4 
Private paediatricians PriPD 4 
Private general practitioners GP 5 
Polyclinicb doctor PY 6 
Preschool principals PP 5 
Parents of children aged 18 months to 7 years Par 4 
Total  40 
a Health promotion agency of the Singapore government, responsible for delivery of routine 621 
immunisations in primary schools 622 
b Government clinic providing subsidised outpatient care, health screenings and pharmacy 623 
services 624 
